His primary areas of investigation include Internal medicine, Surgery, Transplantation, Hematopoietic stem cell transplantation and Bone marrow. His work in Internal medicine addresses issues such as Gastroenterology, which are connected to fields such as Busulfan. His research integrates issues of Epidemiology, Rhabdomyosarcoma and Risk factor in his study of Surgery.
His Transplantation research includes themes of Case-control study, Standardized mortality ratio, Immunology, Total body irradiation and Survival analysis. While the research belongs to areas of Immunology, he spends his time largely on the problem of Graft-versus-host disease, intersecting his research to questions surrounding Mental health, Quality of life and Medical record. His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Young adult, Relative risk and Transplantation Conditioning.
K. Scott Baker focuses on Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Immunology. His Transplantation study integrates concerns from other disciplines, such as Odds ratio, Total body irradiation, Disease and Intensive care medicine. K. Scott Baker combines subjects such as Gastroenterology, Endocrinology and Oncology with his study of Internal medicine.
The concepts of his Gastroenterology study are interwoven with issues in Hemophagocytic lymphohistiocytosis and Cyclophosphamide, Fludarabine, Busulfan. His Hematopoietic stem cell transplantation research also works with subjects such as
His scientific interests lie mostly in Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Pediatrics and Oncology. His Transplantation research is multidisciplinary, relying on both Immunology, Intensive care medicine, Total body irradiation, Bone transplantation and Disease. K. Scott Baker has researched Internal medicine in several fields, including Gastroenterology, Surgery and Preparative Regimen.
His work in the fields of Hematopoietic stem cell transplantation, such as Busulfan, intersects with other areas such as Fanconi anemia. His study on Pediatrics also encompasses disciplines like
His primary areas of study are Transplantation, Internal medicine, Disease, Hematopoietic stem cell transplantation and Intensive care medicine. The concepts of his Transplantation study are interwoven with issues in Young adult and Immunology. The study incorporates disciplines such as Surgery and Oncology in addition to Internal medicine.
His Surgery research is multidisciplinary, incorporating perspectives in Gastroenterology and Paroxysmal nocturnal hemoglobinuria. His Disease research is multidisciplinary, relying on both Severity of illness, Performance status and Anxiety. His study looks at the relationship between Hematopoietic stem cell transplantation and fields such as Transplantation Conditioning, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.
John E. Wagner;Juliet N. Barker;Todd E. DeFor;K. Scott Baker.
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor study
Smita Bhatia;Liton Francisco;Andrea Carter;Can Lan Sun.
Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV
John C. Breneman;Elizabeth Lyden;Alberto S. Pappo;Michael P. Link.
Journal of Clinical Oncology (2003)
Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study
K. Scott Baker;Kirsten K Ness;Julia Steinberger;Andrea Carter.
New Malignancies After Blood or Marrow Stem-Cell Transplantation in Children and Adults: Incidence and Risk Factors
K. Scott Baker;Todd E. DeFor;Linda J. Burns;Norma K.C. Ramsay.
Journal of Clinical Oncology (2003)
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study
Christopher J. Fraser;Smita Bhatia;Kirsten Ness;Andrea Carter.
Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia
James G. Gurney;Kirsten K. Ness;Shalamar D. Sibley;Maura O'Leary.
Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study
Smita Bhatia;Leslie L. Robison;Liton Francisco;Andrea Carter.
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
Can Lan Sun;Liton Francisco;Toana Kawashima;Wendy Leisenring.
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).
Saro H. Armenian;Can Lan Sun;Toana Kawashima;Mukta Arora.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: